ARTICLE | Clinical News
Lifmior regulatory update
December 21, 2016 12:42 AM UTC
EMA’s CHMP recommended approval of Pfizer’s Lifmior etanercept, a product identical to Enbrel, to treat rheumatoid arthritis (RA), juvenile idiopathic arthritis, psoriatic arthritis, axial spondyloart...
BCIQ Company Profiles